COMP <GO>
ULBI vs SES // RSI-14 & 200D SMA MOMENTUM
Ultralife Corporation (NASDAQ) VS. SES AI Corporation (Class A) (NYSE) • 15-METRIC TALLY: ULBI 7
— SES 3
▲ RSI-14 & 200D SMA MOMENTUM LEADER: ULBI
LAST: $15.62 (0.00%) • MKT CAP: $260.3M
rsi-technicals
93.4
LAST: $0.78 (-1.56%) • MKT CAP: $281.3M
rsi-technicals
52.2
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ULBI VS. SES)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ULBI | SES | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 24.10% | 53.80% | -29.70 | SES | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -2.80% | -35.00% | +32.20 | ULBI | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 2.73% | -18.98% | +21.71 | ULBI | /fcf-yield <GO> |
| Operating Margin | -3.10% | -60.00% | +56.90 | ULBI | /operating-margins <GO> |
| Net Profit Margin | -3.10% | -60.00% | +56.90 | ULBI | /net-margins <GO> |
| Revenue Growth (YoY) | 16.20% | 180.00% | -163.80 | SES | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.71 | 1.36 | +1.35 | ULBI | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 5/9 | +1.00 | ULBI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 93.4 | 52.2 | +41.20 | ULBI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $260.3M | $281.3M | -$21.0M | SES | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ULBI REV | SES REV | ULBI GROSS % | SES GROSS % | ULBI FCF | SES FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $191.2M | $21.0M | 24.1% | 53.8% | $7.1M | -$61.2M |
| FY 2024 | $164.5M | $2.0M | 25.7% | 63.1% | $14.7M | -$78.3M |
| FY 2023 | $158.6M | $218.8M | — | — | $1.9M | -$56.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ULBI // BETA —
SES // BETA —